======= C1orf51 ======= == Gene Information == * **Official Symbol**: CIART * **Official Name**: circadian associated repressor of transcription * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=148523|148523]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8N365|Q8N365]] * **Interactions**: [[https://thebiogrid.org/search.php?search=C1orf51&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20C1orf51|Open PubMed]] * **OMIM**: [[https://omim.org/entry/615782|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Transcriptional repressor which forms a negative regulatory component of the circadian clock and acts independently of the circadian transcriptional repressors: CRY1, CRY2 and BHLHE41. In a histone deacetylase-dependent manner represses the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer. Abrogates the interaction of ARNTL/BMAL1 with the transcriptional coactivator CREBBP and can repress the histone acetyl-transferase activity of the CLOCK-ARNTL/BMAL1 heterodimer, reducing histone acetylation of its target genes. Rhythmically binds the E-box elements (5'-CACGTG-3') on circadian gene promoters and its occupancy shows circadian oscillation antiphasic to ARNTL/BMAL1. Interacts with the glucocorticoid receptor (NR3C1) and contributes to the repressive function in the glucocorticoid response (By similarity). {ECO:0000250}. No Pfam Domain information is available for this gene. |locomotor rhythm| |circadian behavior| |rhythmic behavior| |E-box binding| |circadian regulation of gene expression| |RNA polymerase II distal enhancer sequence-specific DNA binding| |PML body| |circadian rhythm| |locomotory behavior| |rhythmic process| |behavior| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |negative regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp539|42°C R08 exp539]]|-1.75| |[[:results:exp170|Metformin 100 to 150μM on day4 R04 exp170]]|1.71| |[[:results:exp187|proTAME 5μM R04 exp187]]|1.79| |[[:results:exp496|Lead acetate 990μM R08 exp496]]|2.36| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6856 * **Expression level (log2 read counts)**: 2.02 {{:chemogenomics:nalm6 dist.png?nolink |}}